A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids

Study Identifier
CMO-CAN-WH-0412
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Uterine Fibroids
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female
    Age
    18+ years

    Protocol Summary

    This study will characterize the treatments and outcomes associated with different uterine fibroid treatments in Canada, to understand patients' preferences and satisfaction with different medical and procedural interventions. The study will also assess the effectiveness of ulipristal acetate (Fibristal®) in controlling bleeding, reducing fibroid volume and symptoms, and improvement in patient's quality of life.

    Study Locations

    Location
    Status
    Location
    Peter Lougheed Centre/University of Calgary
    Calgary, Alberta, Canada, T2E 7W7
    Status
    Not applicable
    Location
    Urestky Edmonton Clinic
    Edmonton, Alberta, Canada, T5T 1L6
    Status
    Not applicable
    Location
    Sanders Vancouver Clinic
    Vancouver, British Columbia, Canada, V5Z 4E1
    Status
    Not applicable
    Location
    Children's and Women's Health Centre of British Columbia - The University of British Columbia
    Vancouver, British Columbia, Canada, V6H 3N1
    Status
    Not applicable
    Location
    Southern Health Centre
    White Rock, British Columbia, Canada, V4B 5C9
    Status
    Not applicable
    Location
    Landau Fredericton Clinic
    Fredericton, New Brunswick, Canada, E3B 6H5
    Status
    Not applicable
    Showing {first} - {last} of {total} Results